About
The Graduate School of Innovative Therapies in Cancerology provides students in science and health, as well as health professionals, with high-level multidisciplinary training centered around emerging therapeutic strategies in oncology and onco-hematology. This includes innovative approaches like immunotherapy, cell therapy, and targeted therapies.
For an extended period, surgery, chemotherapy, and radiotherapy stood as the conventional treatments in cancerology. However, groundbreaking approaches, such as immunotherapy and adoptive cell therapy involving modified cells, have recently surfaced, transforming the therapeutic landscape.
Remarkable clinical progress is also evident, accelerated by novel T-cell engineering techniques, therapeutic combinations, and enhanced insights into the immunosuppressive mechanisms within the microenvironment.
The Graduate School of Innovative Therapies in Cancerology offers its students a unique opportunity to delve into these pioneering therapeutic strategies through a comprehensive curriculum that seamlessly integrates immunology, hematology, and oncology.
Moreover, the Graduate School of Innovative Therapies in Cancerology extends its training outreach to healthcare professionals working in hospitals, regulatory agencies, or the industry, aiming to prepare them for the advent of these innovative molecules in oncology. Lastly, it provides students with research-oriented training, offering internships in research teams affiliated with Université Paris Cité and in industries involved in the development of these molecules, facilitating a smooth transition into the professional sphere.
The Graduate School of Innovative Therapies in Cancerology aspires to…
Develop a comprehensive training program in the realm of innovative therapies in oncology and onco-hematology, including offerings in digital formats.
Facilitate the participation of international students in training within this field and support them in conducting their Master’s internship in laboratories affiliated with Université Paris Cité.
Foster collaborations between Université Paris Cité and international laboratories, allowing students to embark on brief visits to foreign laboratories to acquire expertise in specific techniques.
Encourage interactions among key stakeholders in fundamental, industrial, and clinical research within the domain of therapeutic innovations in oncology and onco-hematology.
Cultivate the development of future leaders in academic and industrial research in the fields of oncology and onco-hematology.